THE BURDEN of high drug costs weighs most heavily on the sickest Americans.
Drug makers have raised prices on treatments for life-threatening or chronic conditions like multiple sclerosis, diabetes and cancer. In turn, insurers have shifted more of those costs onto consumers. Saddled with high deductibles and other out-of-pocket costs that expose them to a drug’s rising list price, many people are paying thousands of dollars a month merely to survive.
For more than a year, President Donald Trump and Democrats in Congress have promised to take action on high drug prices, but despite a flurry of proposals, little has changed.
[For more on this story by Katie Thomas, The New York Times, and Charles Ornstein, ProPublica, go to https://features.propublica.or...-the-price-they-pay/]
Comments (0)